The dermatology
drugs market includes medications that are used for the treatment of skin
conditions such as dermatitis (including eczema), rosacea, hyperhidrosis,
androgenic alopecia, onychomycosis, hair loss, acne, immune disorders
(including psoriasis), microbial infections (bacterial, fungal, and viral),
vascular and pigmented lesion removal, common warts, seborrheic keratosis, and
other skin diseases.
Read More: https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report-2018
The major reason
why the global dermatology drugs market will increase from $33 billion in 2017
to close to $42 billion by 2021 is the increase in the number of indications
treated by topical drugs
The
USA was the largest country in the dermatology drugs market in 2017, accounting
for nearly one-fourth of the market share. The factors attributed to the size
of this market include high quality healthcare facilities, a high cost
healthcare system and the GDP of the country. China and Japan followed the USA as the next
largest countries in the market.
The dermatology
drugs market is fragmented with a number of large and small drugs
organizations. The top five competitors in the market made up around 45% of the
total market in 2017. Johnson & Johnson was the largest competitor of the
market, followed by Allergan Plc. and Galderma S.A. J&J was founded in 1886 and is headquartered in New Jersey, USA. The
company is engaged in the development, manufacturing and marketing of personal
care hygienic products, pharmaceuticals and surgical equipment.
About The Business
Research Company.
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in
the UK, the US and India and a network of trained researchers in 15 countries
globally.
Contact
Information.
The Business Research Company
Europe: +44 207
1930 708
Asia: +91
8897263534
Americas: +1 315
623 0293
No comments:
Post a Comment